Table 5 Median change in pain, function, and quality of life before and after intervention
| Â | Â | Group median (IQR) at study time points | Median change between time points | |||
|---|---|---|---|---|---|---|
Domain | Outcome measure | T0 (n = 10) | T1 (n = 7) | T2 (n = 6) | T0–T1 | T0–T2 |
Pain | BPI-SF | Â | Â | Â | Â | Â |
|  | • Worst pain | 7 (5) | 7 (4) | 5 (2) | 0 |  − 2 |
|  | • Least pain | 2 (3) | 2 (3) | 2 (2) | 0 | 0 |
|  | • Average pain | 4 (2) | 5 (2) | 4 (4) | 1 | 0 |
|  | • Pain now | 3 (4) | 3 (4) | 3 (4) | 0 | 0 |
|  | • Pain interference | 5 (5) | 3.42 (3.15) | 3.28 (3) |  − 1.58 |  − 1.72 |
Self-efficacy | PSEQ | 45 (27) | 39 (27) | 37 (20) |  − 6 |  − 8 |
HR-QoL | EQ5D-5L | Â | Â | Â | Â | Â |
• VAS | 70 (35) | 75 (40) | 70 (10) |  + 5 | 0 | |
• Utility score | 0.649 (0.308) | 0.389 (0.358) | 0.698 (0.07) |  − 0.26 |  + 0.049 | |
|  | MSK-HQ | 30 (14) | 39 (14) | 35.5 (7) |  + 9 |  + 5.5 |
Function | HAL (sum) | 46.9 (33) | 52.3 (39.1) | 49.65 (19.4) | 5.4 | 2.75 |
| Â | PSFS | 3 (1.66) | 3 (1) | 3.33 (0.84) | 0 | 0.33 |